Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105353964 | 10535396 | 4 | F | 20140921 | 20160907 | 20141022 | 20160912 | EXP | JP-GLAXOSMITHKLINE-JP2014JPN008956 | GLAXOSMITHKLINE | 31.33 | YR | F | Y | 52.00000 | KG | 20160912 | CN | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105353964 | 10535396 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 100 MG, QOD | Y | 20241 | 100 | MG | TABLET | QOD | |||||
105353964 | 10535396 | 2 | C | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | UNK | 0 | |||||||||||
105353964 | 10535396 | 3 | C | UNKNOWN DRUG | UNSPECIFIED INGREDIENT | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
105353964 | 10535396 | 1 | Epilepsy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
105353964 | 10535396 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
105353964 | 10535396 | Blister | |
105353964 | 10535396 | Drug eruption | |
105353964 | 10535396 | Oedema peripheral | |
105353964 | 10535396 | Pain in extremity | |
105353964 | 10535396 | Peripheral swelling | |
105353964 | 10535396 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
105353964 | 10535396 | 1 | 20140920 | 20140926 | 0 |